Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Japan's Takeda Pharmaceutical Co. Ltd. (TAK) announced Monday that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE)1 It will be available in 2 mg/10 mL convenient, single-dose stick packs by the end of February.

RTTNews | 631 gün önce

Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

Takeda Canada Inc., the Canadian arm of Japan's Takeda Pharmaceutical Co. Ltd. (TAK) on Wednesday entered into a contract with Canadian Blood Services (CBS) for GLASSIA (alpha-1 proteinase inhibitor) resulting from CBS's request for proposal for hereditary deficiency of Alpha-1 Antitrypsin Deficiency (Alpha-1).

RTTNews | 685 gün önce

Takeda Says Japan Approves CUVITRU Subcutaneous Immunoglobulin For Patients With Agammaglobulinemia

Takeda Pharmaceutical Co. Ltd. (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] in patients aged 2 years and older with agammaglobulinemia or hypogammaglobulinemia disorders.

RTTNews | 771 gün önce

Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD) after induction therapy with ENTYVIO intravenous (IV).

RTTNews | 783 gün önce

China Services Activity Expands On New Business

China's service sector continued to grow in October as new business growth accelerated despite a fall in export sales, survey data published by S&P Global showed on Wednesday. The headline RatingDog service Purchasing Managers' Index fell to 52.6 in October from 52.9 in September. Although the growth was the softest in three months, the sector extended the current period of expansion.

RTTNews | 1s 24 dakika önce

European Shares Set To Follow Wall Street Lower On Tech Valuation Concerns

European stocks may open lower on Wednesday as investors fret about a weakening U.S. economy and highly elevated valuations for many artificial intelligence companies.

RTTNews | 1s 35 dakika önce

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Wednesday, adding to the losses in the previous session, with the benchmark S&P/ASX 200 falling well below the 8,800 level, following the broadly negative cues from Wall Street overnight, dragged by tumbling mining, energy and technology stocks.

RTTNews | 3s 46 dakika önce

Asian Markets A Sea Of Red

Asian stock markets are a sea of red on Wednesday, following the broadly negative cues from Wall Street overnight, dragged by the benchmark indexes in Japan and South Korea which are plunging 4 to 5 percent each on concerns over stretched valuations as global tech stocks tumble on fears that an AI bubble is about to burst. Asian markets closed mostly lower on Tuesday.

RTTNews | 4s 4 dakika önce

EURUSD	1.14922	GBPUSD	1.30274	AUDUSD	0.64937
USDJPY	153.497	USDCAD	1.41091	USDCHF	0.80897